Related Experiment Video
Updated: Nov 14, 2025
09:13
Author Spotlight: Developing Multiplexed Kinetic Assays for Organoid-Based Drug Response Analysis
Published on: January 5, 2024
1.6K
Novel anticancer drugs approved in 2020
Jing Li1, Ruquan Wang1, Jianjun Gao1
1Department of Pharmacology, School of Pharmacy, Qingdao University Medical College, Qingdao, Shandong, China.
Drug Discoveries & Therapeutics
|March 11, 2021
Summary
In 2020, new molecular entities and biologics advanced anticancer drug development. Approved therapies included small molecule inhibitors, antibodies, and antibody drug conjugates (ADCs) to combat cancer.
Area of Science:
- Oncology
- Pharmacology
- Drug Development
Background:
- Cancer remains a significant global health threat with a substantial unmet clinical need for effective treatments.
- Anticancer drug research and development are crucial for improving patient outcomes and survival rates.
Purpose of the Study:
- To review novel anticancer drugs approved in 2020 across major markets (US, EU, Japan, China).
- To highlight key advances in molecular entities and therapeutic biologics for cancer treatment.
Main Methods:
- Systematic review of drug approvals in 2020.
- Analysis of approved anticancer drugs, categorizing them by type (small molecule inhibitors, antibodies, antibody drug conjugates).
Main Results:
- The primary anticancer drugs approved in 2020 were small molecule inhibitors targeting oncogenes, antibodies, and antibody drug conjugates (ADCs).
- These approvals represent significant progress in targeted cancer therapy and biologic drug development.
Conclusions:
- The approved anticancer drugs in 2020 demonstrate a trend towards targeted therapies and advanced biologic agents.
- Future anticancer drug development is expected to focus on novel agents with enhanced target specificity and mechanisms to overcome drug resistance.
Related Concept Videos
01:26FDA Approved Drugs: Changes to Approved Drugs
76
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
76
02:57Targeted Cancer Therapies
8.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.1K
02:49Cancer Therapies
9.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.0K
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
01:30Cancer Vaccines
618
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
618
02:50Combination Therapies and Personalized Medicine
5.6K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.6K